Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

In Vitro High-Throughput RNAi Screening to Accelerate the Process of Target Identification and Drug Development.

Yin H, Kassner M.

Methods Mol Biol. 2016;1470:137-49. doi: 10.1007/978-1-4939-6337-9_11.

PMID:
27581290
2.

Disagreeableness as a Cause and Consequence of Ostracism.

Hales AH, Kassner MP, Williams KD, Graziano WG.

Pers Soc Psychol Bull. 2016 Jun;42(6):782-97. doi: 10.1177/0146167216643933. Epub 2016 Apr 4.

PMID:
27044246
3.

Integrated genomic approaches identify upregulation of SCRN1 as a novel mechanism associated with acquired resistance to erlotinib in PC9 cells harboring oncogenic EGFR mutation.

Kim N, Cho A, Watanabe H, Choi YL, Aziz M, Kassner M, Joung JG, Park AK, Francis JM, Bae JS, Ahn SM, Kim KM, Park JO, Park WY, Ahn MJ, Park K, Koo J, Yin HH, Cho J.

Oncotarget. 2016 Mar 22;7(12):13797-809. doi: 10.18632/oncotarget.7318.

4.

Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression.

Hayes TK, Neel NF, Hu C, Gautam P, Chenard M, Long B, Aziz M, Kassner M, Bryant KL, Pierobon M, Marayati R, Kher S, George SD, Xu M, Wang-Gillam A, Samatar AA, Maitra A, Wennerberg K, Petricoin EF 3rd, Yin HH, Nelkin B, Cox AD, Yeh JJ, Der CJ.

Cancer Cell. 2016 Jan 11;29(1):75-89. doi: 10.1016/j.ccell.2015.11.011. Epub 2015 Dec 24.

5.

STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma.

Evers L, Perez-Mancera PA, Lenkiewicz E, Tang N, Aust D, Knösel T, Rümmele P, Holley T, Kassner M, Aziz M, Ramanathan RK, Von Hoff DD, Yin H, Pilarsky C, Barrett MT.

Genome Med. 2014 Jan 31;6(1):9. doi: 10.1186/gm526. eCollection 2014.

6.

Virtually ostracized: studying ostracism in immersive virtual environments.

Kassner MP, Wesselmann ED, Law AT, Williams KD.

Cyberpsychol Behav Soc Netw. 2012 Aug;15(8):399-403. doi: 10.1089/cyber.2012.0113.

7.

Kinome-wide siRNA screening identifies molecular targets mediating the sensitivity of pancreatic cancer cells to Aurora kinase inhibitors.

Xie L, Kassner M, Munoz RM, Que QQ, Kiefer J, Zhao Y, Mousses S, Yin HH, Von Hoff DD, Han H.

Biochem Pharmacol. 2012 Feb 15;83(4):452-61. doi: 10.1016/j.bcp.2011.11.005. Epub 2011 Nov 15.

8.

Functional genomics reveals diverse cellular processes that modulate tumor cell response to oxaliplatin.

Harradine KA, Kassner M, Chow D, Aziz M, Von Hoff DD, Baker JB, Yin H, Pelham RJ.

Mol Cancer Res. 2011 Feb;9(2):173-82. doi: 10.1158/1541-7786.MCR-10-0412. Epub 2010 Dec 17.

9.

X-ray microbeam measurements of individual dislocation cell elastic strains in deformed single-crystal copper.

Levine LE, Larson BC, Yang W, Kassner ME, Tischler JZ, Delos-Reyes MA, Fields RJ, Liu W.

Nat Mater. 2006 Aug;5(8):619-22. Epub 2006 Jul 16.

PMID:
16845413
10.

Severe toxoplasmic ventriculomeningoencephalomyelitis in two AIDS patients following treatment of cerebral toxoplasmic granuloma.

Artigas J, Grosse G, Niedobitek F, Kassner M, Risch W, Heise W.

Clin Neuropathol. 1994 May-Jun;13(3):120-6.

PMID:
8088031
11.

Silicide layer growth rates in Mo/Si multilayers.

Rosen RS, Vernon DS, Stearns G, Viliardos MA, Kassner ME, Cheng Y.

Appl Opt. 1993 Dec 1;32(34):6975-80. doi: 10.1364/AO.32.006975.

PMID:
20856554

Supplemental Content

Loading ...
Support Center